Ang1 and Ang2 have been identi®ed as ligands of the endothelial cell-speci®c Tie2 receptor Maisonpierre et al., 1997) . In vivo analyses by targeted gene inactivation and transgenic overexpression suggest that Ang1 recruits and sustains periendothelial support cells while Ang2 disrupts blood vessel formation in the developing embryo by antagonizing the eects of Ang1 on Tie2 (Maisonpierre et al., 1997; Suri et al., 1996) . In adult, endothelial cells from dierent areas have dierent characteristics themselves and their responses to growth factors are dierent (Risau, 1995) . Transgenic overexpression or gene transfer of Ang1 increases vascularization (Suri et al., 1998; Shyu et al., 1998) and decreases vascular leakage in vivo (Thurston et al., 1999 (Thurston et al., , 2000 . However, gene transfer of Ang2 does not produce signi®cant vascularization in ischemic limbs (Shyu et al., 1998) . In a mouse corneal micropocket assay, both Ang1 and Ang2 failed to stimulate an angiogenic response when administered alone (Asahara et al., 1998) . However, when co-administered with VEGF, both Ang1 and Ang2 augmented the formation of neovessels (Asahara et al., 1998) . Ectopic expression of Ang2 in Ang2 nonexpressing cells promotes tumor angiogenesis when those cells are implanted in nude mice (Tanaka et al., 1999) . In vitro experiments have shown that Ang1 has speci®c eects on endothelial cells: it potently induces chemotactic response (Witzenbichler et al., 1998) , network formation , sprouting (Koblizek et al., 1998; Kim et al., 1999) and survival in apoptosis Kim et al., 2000a) . Although a recent report indicates that Ang2 (250 ng/ml) stimulates proliferation, migration, and release of nitric oxide in trophoblast cells that are expressing the Tie2 receptor (Dunk et al., 2000) , the role of Ang2 on cultured endothelial cells is not known.
While Ang1 mRNA is mainly expressed in periendothelial cells, including vascular smooth muscle cells Suri et al., 1996; Kim et al., 2000a) , Ang2 mRNA is selectively expressed in endothelial cells (Maisonpierre et al., 1997) . To date, the regulation of Ang1 mRNA expression is an unknown, but we do have some information about the regulation of Ang2. Hypoxia, vascular endothelial growth factor (VEGF) and basic ®broblast growth factor upregulate Ang2 expression in endothelial cells (Mandriota and Pepper, 1998; Oh et al., 1999) . Interestingly, high levels of Ang2 mRNA are observed in highly vascularized glioblastoma and hepatocellular carcinoma (Stratmann et al., 1998; Tanaka et al., 1999) . During tumor angiogenesis, endothelial cell survival is a prerequisite for initiating mitosis, migration, and organization into primitive angiotubes and patent vascular networks (Risau, 1997; Hanahan, 1997 ). Thus, a high level of Ang2 could be a critical factor for tumor angiogenesis through endothelial cell survival. Therefore, in this study, we examined the eect of various concentrations of Ang2 on the survival in the primary cultured human umbilical vein endothelial cells (HUVECs). We obtained Ang2 and soluble Tie2 receptor-Fc (rTie2-Fc) fusion proteins from Regeneron Pharmaceuticals, Inc. and R&D systems. The Ang1 recombinant protein was produced from COS-7 cells and puri®ed using a Ni-NTA agarose column (Qiagen) as described previously .
Serum deprivation caused apoptosis in HUVECs. There were more¯oating and fewer adherent cells seen with phase-contrast microscopy, and fragmented DNA detected with a TUNEL assay ( Figure 1a ). The proportion of¯oating apoptotic cells to total apoptotic cells was approximately 25% at 24 h after serum deprivation. Approximately 33% of the total cells underwent apoptosis during serum-deprivation. Although 50 ± 400 ng/ml of Ang2 did not produce any signi®cant antiapoptotic eect, surprisingly, 800 ng/ml of Ang2 produced a signi®cant antiapoptotic eect during serum-deprived apoptosis (Figure 1a ,b). The cells exposed to Ang2 (800 ng/ml) were more adherent and fewer were TUNEL-positive than the cells exposed to control buer during serum deprivation ( Figure 1a ). As a positive control, 50 ± 800 ng/ml of Ang1 produced an antiapoptotic eect in a dosedependent manner (Figure 1b ). High levels of Ang2 Figure 1 Eect of Ang2 on serum deprivation-induced apoptosis in HUVECs. (a) Representative phase-contrast microscopy (upper panels) and light microscopy of TUNEL assay (lower panels). Note that there are fewer adherent cells and more¯oating dead cells after 24 h of serum deprivation compared to cultured in 10% serum. The cells exposed to Ang2 (800 ng/ml) are more adherent than the cells exposed to control buer. Brown TUNEL positives indicate apoptotic cells with fragmented DNA. Magni®cations are 2006 (Phase) and 4006 (TUNEL). HUVECs were prepared from human umbilical cords by collagenase digestion as previously described . HUVECs were maintained in M-199 medium supplemented with 20% heatinactivated fetal bovine serum (FBS). To assay apoptosis, HUVECs were plated onto gelatinized 24-well plates (5610 4 cells per well) in M-199 containing 10% FBS and incubated for 24 h. Then the wells were extensively washed with phosphate buered saline (PBS), and the medium was changed to serum-free M-199 containing the indicated concentration of Ang1 or Ang2 and incubated for 24 h. Apoptosis was assayed 24 h after serum deprivation. (b) Quanti®cation of apoptosis. Data are expressed as mean+s.d. of ®ve experiments. S, 10% FBS; CB, control buer. Statistical signi®cance was tested using one-way ANOVA followed by the Student-Newman-Keuls test. *P50.05 versus CB. Quanti®cation of apoptosis was performed as described previously (Kim et al., 2000a) . Brie¯y,¯oating cells were collected with two PBS washes; adherent cells were collected by trypsinization. The numbers and size distributions of the¯oating and adherent cells were measured with a Coulter Model Z1 Dual Counter System. More than 95% of the¯oating cells were apoptotic cells, as con®rmed by a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay kit (Oncor). To detect the apoptotic cells among the adherent cells, the cells in parallel wells were washed with PBS, ®xed for 5 min with 1.0% (wt/vol) paraformaldehyde, and subjected to a TUNEL assay. The adherent cells were examined at 4006 magni®cation, and the stained cells were counted in four dierent random locations, each containing approximately 250 cells. The percentage of apoptotic cells is based on the sum of the¯oating cells plus the apoptotic adherent cells in a given cell population Angiopoietin-2 survival pathway in endothelial cells I Kim et al mRNA are observed in highly vascularized glioblastoma and hepatocellular carcinoma (Stratmann et al., 1998; Tanaka et al., 1999) . Moreover, our recent study indicates that expression of Ang2 mRNA is detected not only in primary endothelial cells, but also in several non-endothelial tumor cell lines, primary tumor tissues, and macrophages (Kim et al., 2000b) . Rapidly proliferating tumor cells are growing under hypoxic conditions (Hanahan and Folkman, 1996) . Highly vascularized tumors contain high levels of several growth factors (Hanahan and Folkman, 1996) . In fact, hypoxia and growth factors are known to be stimulants for Ang2 expression (Mandriota and Pepper, 1998; Oh et al., 1999) . Therefore, the local concentration of Ang2 could be high in tumor areas during angiogenesis. In fact, histological analyses indicate that Ang2 expression is high during tumor angiogenesis, both at early and later stages of vascular activation (Holash et al., 1999) . Thus, the present results suggest that our high concentration of Ang2 may be physiologically relevant to certain pathological states, and it may be an endothelial cell survival factor for tumor angiogenesis. To determine possible pathways for an antiapoptotic eect mediated by high concentration Ang2, HUVECs were pretreated with soluble Tie2 receptor and PI 3'-kinase inhibitors. Ang2 at 800 ng/ml inhibited approximately 35 ± 40% of the apoptotic events (Figure 2) . A ®vefold molar excess of rTie2-Fc completely blocked Ang2's antiapoptotic eect (Figure 2) . Two speci®c inhibitors of PI 3'-kinase, wortmannin and LY294002, almost completely blocked the Ang2 (800 ng/ml)-induced antiapoptotic eect (Figure 2 ). Both reagents slightly enhanced the degree of apoptosis observed in the absence of Ang2, possibly because of inhibition of basal PI 3'-kinase activity present in serum-deprived cells. These results suggest that Ang2, like Ang1, exerts its antiapoptotic eect in endothelial cells through Tie2 receptor binding and a PI 3'-kinase-mediated pathway.
Biochemical analyses indicated that 800 ng/ml of Ang2 induced the Tie2 phosphorylation (3.8+0.5-fold) Figure 3 Eect of Ang2 on the phosphorylation of Tie2, the p85 subunit of PI 3'-kinase, and Akt at Ser473; and on the activity of PI 3'-kinase. (a,b,d) Phosphorylation assays of Tie2, the p85 subunit of PI 3'-kinase, and Akt at Ser473. Cells were incubated for 24 h in serum-free medium before Ang2 addition. The indicated amounts of Ang2 or Ang1 were added to cells and incubated for 10 min (for Tie2 and p85 subunit of PI 3'-kinase) or for 45 min (for Akt at Ser473). The cell lysates were immunoprecipitated with anti-Tie2 antibody (Santa Cruz Biotechnology) or anti-p85 antibody (Upstate Biotechnology, Inc), and separated by SDS ± PAGE. After Western blotting with antiphosphotyrosine antibody (Upstate Biotechnology, Inc) (upper panels), the membranes were stripped and re-incubated with corresponding antibodies (lower panels) for detection of total Tie2 or p85 protein, as described previously (Kim et al., 2000a) . The Akt at Ser473 phosphorylation assay was performed according to the manufacturer's protocol (New England BioLabs). In lanes 800W and 200W, wortmannin (30 nM) was added to the cells 30 min before exposure to Ang2 (800 ng/ml) and Ang1 200 ng/ml). (c) Autoradiogram of thin-layer chromatography for PI 3'-kinase activity, performed as described previously (Kim et al., 2000a) . Cells exposed to Ang2 for 10 min generated visible induction of phosphatidylinositol-3-monophosphate (PIP). The results from 3 ± 5 experiments were similar. (e) Densitometric analysis shows the relative ratio of phosphorylated Tie2/total Tie2, phosphorylated p85/total p85, PIP/origin, and phosphorylated Akt/total Akt. The ratio for the control is arbitrarily presented as 1. Data are presented as mean+s.e. of the ratios from three or ®ve experiments. *P50.05 versus control buer (0); # P50.05 versus Ang2 (800 ng/ml) only; {P50.05 versus Ang1 (200 ng/ml) only Figure 2 Eect of rTie2-Fc and PI 3'-kinase inhibitors on antiapoptotic eect of Ang2. A ®vefold molar excess of rTie2-Fc (8 mg/ml) (T2), wortmannin (30 nM) (WT) or LY294002 (100 nM) (LY) was added to HUVECs in serum-free medium. After 1 h, Ang2 (800 ng/ml) was added and incubated for 24 h. The cells are prepared, cultured, and assayed as described in Figure 1 . Data are expressed as the mean+s.d. of ®ve independent experiments. S, 10% FBS; CB, control buer. Statistical signi®cance was tested using one-way ANOVA followed by the Student-Newman-Keuls test. *P50.05 versus S; # P50.05 versus CB with serum deprivation Oncogene Angiopoietin-2 survival pathway in endothelial cells I Kim et al and PI 3'-kinase activity (6.8+1.2-fold), whereas 200 ng/ml of Ang2 did not induce Tie2 phosphorylation and PI 3'-kinase activity (Figure 3a,b,e) . Accordingly, 800 ng/ml of Ang2 induced the phosphorylation of the p85 subunit of PI 3'-kinase (3.1+0.3-fold) (Figure 3c,e) . Thus, the antiapoptotic eect of high concentration Ang2 may be mediated through activation of the Tie-2 receptor and PI 3'-kinase. To examine whether Akt activation is involved in this antiapoptotic eect, Akt phosphorylation at Ser473 was examined in whole cell lysates of HUVECs by means of a phosphospeci®c antibody. Ang2 (800 ng/ml) increased Akt phosphorylation at Ser473 by 3.1+0.3-fold whereas Ang1 (200 ng/ml) increased its phosphorylation by 6.4+1.2-fold (Figure 3d,e) . The PI 3'-kinase inhibitor wortmannin completely abolished Akt activation in response to Ang2 (800 ng/ml) and Ang1 (200 ng/ml) (Figure 3d,e) . Thus, Ang2-induced endothelial cell survival may be mediated by PI 3'-kinase and Akt phosphorylation at Ser473.
These results indicate that Ang2 exerts its antiapoptotic eect in endothelial cells through Tie2 receptor binding, and through a PI 3'-kinase-and Akt-mediated pathway. We recently demonstrated that Ang1-induced endothelial cell survival is mediated through activation of Tie2, PI 3'-kinase, and Akt (Kim et al., 2000a) . Thus, our present results indicate that Ang2 induces endothelial cell survival through the same pathway. Akt has been shown to promote cell survival through its ability to phosphorylate Bad and procaspase-9 (Datta et al., 1997; Cardone et al., 1998) . In addition, Papapetropoulos et al. (2000) recently demonstrated that Ang1 can induce cell survival by an induction of the apoptosis inhibitor, survivin, through PI 3'-kinase/Akt activation. Therefore, in future studies, we will examine the exact downstream pathways of Ang2-induced PI 3'-kinase/Akt activation for endothelial cell survival against apoptotic death.
In summary, our results indicate that a high concentration of angiopoietin-2, like angiopoietin-1, can be an apoptosis survival factor for endothelial cells through the activation of the Tie2 receptor, PI 3'-kinase, and Akt. Thus, high concentration of Ang2 in tumor areas may be a positive regulator for tumor angiogenesis.
